Open Access Software

GeVaDSs – decision support system for novel Genetic Vaccine development process

Jacek Blazewicz12, Marcin Borowski1, Wahiba Chaara345, Pawel Kedziora1, David Klatzmann3456, Piotr Lukasiak12, Adrien Six34 and Pawel Wojciechowski1*

Author Affiliations

1 Institute of Computing Science, Poznań University of Technology, 60-965 Poznań, Poland

2 Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, 61-714, Poland

3 CNRS, UMR 7211, Immunology, Immunopathology, Immunotherapy, 75013 Paris, France

4 UPMC Univ Paris 06, UMR 7211, Integrative Immunology team, 75013 Paris, France

5 AP-HP, Pitié Salpêtrière Hospital, Department of Biotherapy, 75013 Paris, France

6 INSERM, U959, Immunology, Immunopathology, Immunotherapy, 75013 Paris, France

For all author emails, please log on.

BMC Bioinformatics 2012, 13:91  doi:10.1186/1471-2105-13-91

Published: 10 May 2012

Additional files

Additional file 1:

A simulated example of GeVaDSs use. Testing the potential of a newly isolated virus as a new vaccine platform.

Format: PDF Size: 1.1MB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data

Additional file 2:

GeVaDSs workflow. The different steps of the GeVaDSs workflow are summarized in the light of the example provided in Additional file 1.

Format: PDF Size: 7KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data